Detalhe da pesquisa
1.
EGFR activation limits the response of liver cancer to lenvatinib.
Nature
; 595(7869): 730-734, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34290403
2.
Cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinoma.
Nat Commun
; 15(1): 2581, 2024 Mar 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38519484
3.
Rational combination of SHP2 and mTOR inhibition for the treatment of hepatocellular carcinoma.
Mol Oncol
; 17(6): 964-980, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36650715
4.
CD103+ regulatory T cells underlie resistance to radio-immunotherapy and impair CD8+ T cell activation in glioblastoma.
Nat Cancer
; 4(5): 665-681, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37081259
5.
Multiparametric Analyses of Hepatocellular Carcinoma Somatic Mouse Models and Their Associated Tumor Microenvironment.
Curr Protoc
; 1(6): e147, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-34101385
6.
Experimental Simulation of the Effects of an Initial Antibiotic Treatment on a Subsequent Treatment after Initial Therapy Failure.
Antibiotics (Basel)
; 3(1): 49-63, 2014 Feb 17.
Artigo
Inglês
| MEDLINE | ID: mdl-27025733